A citation-based method for searching scientific literature

Sam Q Sun, Ammar H Hawasli, Jiayi Huang, Michael R Chicoine, Albert H Kim. Neurosurg Focus 2015
Times Cited: 79







List of co-cited articles
460 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
36

Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
Leland Rogers, Igor Barani, Marc Chamberlain, Thomas J Kaley, Michael McDermott, Jeffrey Raizer, David Schiff, Damien C Weber, Patrick Y Wen, Michael A Vogelbaum. J Neurosurg 2015
290
35

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
30

WHO grade II and III meningiomas: a study of prognostic factors.
Anne Durand, François Labrousse, Anne Jouvet, Luc Bauchet, Michel Kalamaridès, Philippe Menei, Robert Deruty, Jean Jacques Moreau, Michelle Fèvre-Montange, Jacques Guyotat. J Neurooncol 2009
200
30

Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
Manish K Aghi, Bob S Carter, Garth R Cosgrove, Robert G Ojemann, Sepideh Amin-Hanjani, Robert L Martuza, William T Curry, Fred G Barker. Neurosurgery 2009
300
29

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
Thomas J Kaley, Patrick Wen, David Schiff, Keith Ligon, Sam Haidar, Sasan Karimi, Andrew B Lassman, Craig P Nolan, Lisa M DeAngelis, Igor Gavrilovic,[...]. Neuro Oncol 2015
142
25

Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection.
Sam Q Sun, Chunyu Cai, Rory K J Murphy, Todd DeWees, Ralph G Dacey, Robert L Grubb, Keith M Rich, Gregory J Zipfel, Joshua L Dowling, Eric C Leuthardt,[...]. Neurosurgery 2014
62
27

The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection.
Douglas A Hardesty, Andrew B Wolf, David G Brachman, Heyoung L McBride, Emad Youssef, Peter Nakaji, Randall W Porter, Kris A Smith, Robert F Spetzler, Nader Sanai. J Neurosurg 2013
100
20

Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.
Thomas Kaley, Igor Barani, Marc Chamberlain, Michael McDermott, Katherine Panageas, Jeffrey Raizer, Leland Rogers, David Schiff, Michael Vogelbaum, Damien Weber,[...]. Neuro Oncol 2014
121
20

Radiotherapy for atypical meningiomas.
Richard Mair, Kevin Morris, Ian Scott, Thomas A Carroll. J Neurosurg 2011
119
20

EANO guidelines for the diagnosis and treatment of meningiomas.
Roland Goldbrunner, Giuseppe Minniti, Matthias Preusser, Michael D Jenkinson, Kita Sallabanda, Emmanuel Houdart, Andreas von Deimling, Pantelis Stavrinou, Florence Lefranc, Morten Lund-Johansen,[...]. Lancet Oncol 2016
368
20

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Felix Sahm, Daniel Schrimpf, Damian Stichel, David T W Jones, Thomas Hielscher, Sebastian Schefzyk, Konstantin Okonechnikov, Christian Koelsche, David E Reuss, David Capper,[...]. Lancet Oncol 2017
322
20

Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas.
Michael E Sughrue, Nader Sanai, Gopal Shangari, Andrew T Parsa, Mitchel S Berger, Michael W McDermott. J Neurosurg 2010
88
18

Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
Gurvinder Kaur, Eli T Sayegh, Andrew Larson, Orin Bloch, Michelle Madden, Matthew Z Sun, Igor J Barani, C David James, Andrew T Parsa. Neuro Oncol 2014
121
18

Prognostic factors for patients with atypical or malignant meningiomas treated at a single center.
Peng Zhao, Mengqing Hu, Meng Zhao, Xiaohui Ren, Zhongli Jiang. Neurosurg Rev 2015
42
35

Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection.
Sam Q Sun, Albert H Kim, Chunyu Cai, Rory K J Murphy, Todd DeWees, Peter Sylvester, Ralph G Dacey, Robert L Grubb, Keith M Rich, Gregory J Zipfel,[...]. Neurosurgery 2014
75
18

Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
Salah Hammouche, Simon Clark, Alex Hie Lin Wong, Paul Eldridge, Jibril Osman Farah. Acta Neurochir (Wien) 2014
90
17

Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria.
Blake E Pearson, James M Markert, Winfield S Fisher, Barton L Guthrie, John B Fiveash, Cheryl A Palmer, Kristen Riley. Neurosurg Focus 2008
126
16

Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
S-Y Yang, C-K Park, S-H Park, D G Kim, Y S Chung, H-W Jung. J Neurol Neurosurg Psychiatry 2008
178
16

Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy.
T W Dziuk, S Woo, E B Butler, J Thornby, R Grossman, W S Dennis, H Lu, L S Carpenter, J K Chiu. J Neurooncol 1998
187
16

The role of radiotherapy following gross-total resection of atypical meningiomas.
Ricardo J Komotar, J Bryan Iorgulescu, Daniel M S Raper, Eric C Holland, Kathryn Beal, Mark H Bilsky, Cameron W Brennan, Viviane Tabar, Jonathan H Sherman, Yoshiya Yamada,[...]. J Neurosurg 2012
110
15

Pathological classification and molecular genetics of meningiomas.
Christian Mawrin, Arie Perry. J Neurooncol 2010
264
15

Atypical and anaplastic meningiomas treated with bevacizumab.
Lakshmi Nayak, Fabio M Iwamoto, Jeremy D Rudnick, Andrew D Norden, Eudocia Quant Lee, Jan Drappatz, Antonio Omuro, Thomas J Kaley. J Neurooncol 2012
109
15


The accuracy of meningioma grading: a 10-year retrospective audit.
J Willis, C Smith, J W Ironside, S Erridge, I R Whittle, D Everington. Neuropathol Appl Neurobiol 2005
140
15

Local control and overall survival in atypical meningioma: a retrospective study.
L K Goyal, J H Suh, D S Mohan, R A Prayson, J Lee, G H Barnett. Int J Radiat Oncol Biol Phys 2000
171
15

Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.
Chenyang Wang, Tania B Kaprealian, John H Suh, Charlotte D Kubicky, Jeremy N Ciporen, Yiyi Chen, Jerry J Jaboin. Neuro Oncol 2017
53
22

Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
Leland Rogers, Peixin Zhang, Michael A Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh M Modi, Anthony M Alleman, James Galvin, David Brachman, Joseph M Jenrette,[...]. J Neurosurg 2018
103
15

Intracranial meningiomas of atypical (WHO grade II) histology.
Leland Rogers, Mark Gilbert, Michael A Vogelbaum. J Neurooncol 2010
104
13

Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Victoria E Clark, E Zeynep Erson-Omay, Akdes Serin, Jun Yin, Justin Cotney, Koray Ozduman, Timuçin Avşar, Jie Li, Phillip B Murray, Octavian Henegariu,[...]. Science 2013
474
13

Epidemiology and etiology of meningioma.
Joseph Wiemels, Margaret Wrensch, Elizabeth B Claus. J Neurooncol 2010
580
13

"Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.
A Perry, B W Scheithauer, S L Stafford, C M Lohse, P C Wollan. Cancer 1999
432
13

The role of adjuvant radiotherapy in atypical meningioma.
Hae Jin Park, Hyun-Cheol Kang, Il Han Kim, Sung-Hye Park, Dong Gyu Kim, Chul-Kee Park, Sun Ha Paek, Hee-Won Jung. J Neurooncol 2013
84
13

The role of adjuvant radiotherapy after gross total resection of atypical meningiomas.
Shaakir Hasan, Michael Young, Trevine Albert, Ashish H Shah, Christian Okoye, Amade Bregy, Simon S Lo, Fazilat Ishkanian, Ricardo J Komotar. World Neurosurg 2015
51
21


Efficacy of postoperative radiotherapy for high grade meningiomas.
Yunseon Choi, Do Hoon Lim, Kyungil Jo, Do-Hyun Nam, Ho Jun Seol, Jung-Il Lee. J Neurooncol 2014
24
45

Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.
Varun R Kshettry, Quinn T Ostrom, Carol Kruchko, Ossama Al-Mefty, Gene H Barnett, Jill S Barnholtz-Sloan. Neuro Oncol 2015
98
13

Early adjuvant radiotherapy in the treatment of atypical meningioma.
Michael D Jenkinson, Mueez Waqar, Jibril Osman Farah, Michael Farrell, Giuseppe M V Barbagallo, Robin McManus, Seamus Looby, Deirdre Hussey, David Fitzpatrick, Francesco Certo,[...]. J Clin Neurosci 2016
45
24

Adjuvant radiotherapy for atypical meningiomas.
Hilary P Bagshaw, Lindsay M Burt, Randy L Jensen, Gita Suneja, Cheryl A Palmer, William T Couldwell, Dennis C Shrieve. J Neurosurg 2017
53
20

Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.
Ayal A Aizer, Nils D Arvold, Paul Catalano, Elizabeth B Claus, Alexandra J Golby, Mark D Johnson, Ossama Al-Mefty, Patrick Y Wen, David A Reardon, Eudocia Q Lee,[...]. Neuro Oncol 2014
58
17

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
Priscilla K Brastianos, Peleg M Horowitz, Sandro Santagata, Robert T Jones, Aaron McKenna, Gad Getz, Keith L Ligon, Emanuele Palescandolo, Paul Van Hummelen, Matthew D Ducar,[...]. Nat Genet 2013
373
12

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
Andrew D Norden, Jeffrey J Raizer, Lauren E Abrey, Kathleen R Lamborn, Andrew B Lassman, Susan M Chang, W K Alfred Yung, Mark R Gilbert, Howard A Fine, Minesh Mehta,[...]. J Neurooncol 2010
107
12

A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Daniel J Ferraro, Ryan K Funk, John William Blackett, Michelle R Ju, Todd A DeWees, Michael R Chicoine, Joshua L Dowling, Keith M Rich, Robert E Drzymala, Imran Zoberi,[...]. Radiat Oncol 2014
39
25

Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
E B Hug, A Devries, A F Thornton, J E Munzenride, F S Pardo, E T Hedley-Whyte, M R Bussiere, R Ojemann. J Neurooncol 2000
213
12

The ROAM/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial.
Michael D Jenkinson, Mohsen Javadpour, Brian J Haylock, Bridget Young, Helen Gillard, Jacqui Vinten, Helen Bulbeck, Kumar Das, Michael Farrell, Seamus Looby,[...]. Trials 2015
101
12

Review of controversies in management of non-benign meningioma.
Iddo Paldor, Mohammed Awad, Yuval Z Sufaro, Andrew H Kaye, Yigal Shoshan. J Clin Neurosci 2016
23
43

Radiation Treatment for WHO Grade II and III Meningiomas.
Brian P Walcott, Brian V Nahed, Priscilla K Brastianos, Jay S Loeffler. Front Oncol 2013
49
18

The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
Winward Choy, Won Kim, Daniel Nagasawa, Stephanie Stramotas, Andrew Yew, Quinton Gopen, Andrew T Parsa, Isaac Yang. Neurosurg Focus 2011
119
11

Radiotherapy as an adjuvant in the management of intracranial meningiomas: are we practising evidence-based medicine?
H J Marcus, S J Price, M Wilby, T Santarius, R W Kirollos. Br J Neurosurg 2008
66
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.